近日，美国食品药品管理局（FDA）调查结果显示，一名八岁男童的死亡事故与Sarepta的基因疗法"无 关"。 （文章来源：华尔街见闻） 罗氏制药将恢复在美国市场之外的基因疗法Elevidys发货工作。 ...

罗氏制药将恢复在美国市场之外的基因疗法Elevidys发货工作。 近日，美国食品药品管理局（FDA）调查结果显示，一名八岁男童的死亡事故与Sarepta的基因疗法"无 关"。 ...

罗氏将恢复美国以外地区的基因疗法Elevidys的发货。 ...

诺和诺德大跌21.6%，这家丹麦制药巨头下调全年销售额和利润预期。惠而浦大跌12.9%，这家家电企 业Q2业绩不及预期。生物技术公司Sarepta Therapeutics涨35.7%，公司获FDA批准恢复基因疗法Elevidys 用于杜氏肌营养不良症(DMD)治疗。大全新能源涨4.7%，光伏行业迎来情绪范式转变，小摩看好。 ...

Group 1 - Major stock index futures are showing positive movement, with Dow futures up 0.16%, S&P 500 futures up 0.24%, and Nasdaq futures up 0.40% [1] - Technology stocks are mostly rising, with Nvidia up over 1.5% and AMD and Advanced Micro Devices up over 1% [2] - Some Chinese concept stocks are experiencing significant gains, with Li Auto up over 4%, Global Data up over 3%, and Miniso and NIO up over 1% [2] Group 2 - Nvidia reportedly placed an order for 300,000 H20 chips from TSMC, contributing to its pre-market rise of over 1.5% [4] - Sarepta Therapeutics saw a pre-market surge of over 40% after the FDA authorized the resumption of its gene therapy Elevidys for treating Duchenne muscular dystrophy [5] - Apple announced the closure of its first direct store in China, located in Dalian, due to the departure of several retailers from the shopping center, with the store set to close on August 9, 2025 [6] Group 3 - Ford has signed a new $3 billion term loan agreement, which will last until July 28, 2026, with drawn loans maturing on December 31, 2028 [8] - Stellantis reported a 13% year-over-year decline in net revenue for the first half of 2025, totaling €74.3 billion, primarily due to declines in North America and Europe, resulting in a net loss of €2.3 billion compared to a net profit of €5.6 billion in the same period last year [9]